52 related articles for article (PubMed ID: 21622187)
21. Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
Willemse JL; Heylen E; Nesheim ME; Hendriks DF
J Thromb Haemost; 2009 Dec; 7(12):1962-71. PubMed ID: 19719827
[TBL] [Abstract][Full Text] [Related]
22. A role for procarboxypepidase U (TAFI) in thrombosis.
Willemse JL; Hendriks DF
Front Biosci; 2007 Jan; 12():1973-87. PubMed ID: 17127436
[TBL] [Abstract][Full Text] [Related]
23. Carboxypeptidase U at the interface between coagulation and fibrinolysis.
Schatteman K; Goossens F; Leurs J; Verkerk R; Scharpé S; Michiels JJ; Hendriks D
Clin Appl Thromb Hemost; 2001 Apr; 7(2):93-101. PubMed ID: 11292199
[TBL] [Abstract][Full Text] [Related]
24. Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge.
Willemse JL; Hendriks DF
Clin Chem; 2006 Jan; 52(1):30-6. PubMed ID: 16299049
[TBL] [Abstract][Full Text] [Related]
25. Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.
Leurs J; Hendriks D
Thromb Haemost; 2005 Sep; 94(3):471-87. PubMed ID: 16268459
[TBL] [Abstract][Full Text] [Related]
26. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
[TBL] [Abstract][Full Text] [Related]
27. Thrombin activatable fibrinolysis inhibitor.
Declerck PJ
Hamostaseologie; 2011 Aug; 31(3):165-6, 168-73. PubMed ID: 21629966
[TBL] [Abstract][Full Text] [Related]
28. Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders.
Boffa MB; Nesheim ME; Koschinsky ML
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):59-74. PubMed ID: 12769657
[TBL] [Abstract][Full Text] [Related]
29. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Bouma BN; Meijers JC
Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
[TBL] [Abstract][Full Text] [Related]
30. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
[TBL] [Abstract][Full Text] [Related]
31. Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis.
Campbell W; Okada N; Okada H
Immunol Rev; 2001 Apr; 180():162-7. PubMed ID: 11414358
[TBL] [Abstract][Full Text] [Related]
32. Thrombin and fibrinolysis.
Nesheim M
Chest; 2003 Sep; 124(3 Suppl):33S-9S. PubMed ID: 12970122
[TBL] [Abstract][Full Text] [Related]
33. [Basic carboxypeptidases of blood: significance for coagulology].
Timofeev АV
Biomed Khim; 2016; 62(2):141-9. PubMed ID: 27143370
[TBL] [Abstract][Full Text] [Related]
34. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.
Sillen M; Declerck PJ
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916027
[TBL] [Abstract][Full Text] [Related]
35. Novel or expanding current targets in fibrinolysis.
Wyseure T; Declerck PJ
Drug Discov Today; 2014 Sep; 19(9):1476-82. PubMed ID: 24886765
[TBL] [Abstract][Full Text] [Related]
36. Thrombin activatable fibrinolysis inhibitor: a putative target to enhance fibrinolysis.
Vercauteren E; Gils A; Declerck PJ
Semin Thromb Hemost; 2013 Jun; 39(4):365-72. PubMed ID: 23457049
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in thrombin-activatable fibrinolysis inhibitor research.
Marx PF; Verkleij CJ; Valls Seron M; Meijers JC
Mini Rev Med Chem; 2009 Sep; 9(10):1165-73. PubMed ID: 19534693
[TBL] [Abstract][Full Text] [Related]
38. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
Bajzar L; Jain N; Wang P; Walker JB
Crit Care Med; 2004 May; 32(5 Suppl):S320-4. PubMed ID: 15118538
[TBL] [Abstract][Full Text] [Related]
39. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
Urano T
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
[TBL] [Abstract][Full Text] [Related]
40. TAFIa inhibitors in the treatment of thrombosis.
Bunnage ME; Owen DR
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):480-6. PubMed ID: 18600565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
